|
|
|
By Rajendran (Raj) Arunagiri | One of the toughest challenges facing small molecule drug development today is poor solubility of the API. No single technique has universal application, so several strategies exist. This article examines four notable strategies. |
|
|
|
By Anke Rosch, Boehringer Ingelheim | Statistics have been showing that rodent and non-rodent experiments predict human toxicity in only 48-71% of drugs. The FDA Modernization Act 2.0 of 2022 permits the use of suitable animal-free new approach methodologies, and the European Parliament launched a program to eliminate animal studies "as soon as scientifically possible." Let's take a data-driven, research-driven look at the topic. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
